Search Results - "Cusimano, P"

Refine Results
  1. 1

    Influence of metabolic syndrome on hypertension‐related target organ damage by MULÈ, G., NARDI, E., COTTONE, S., CUSIMANO, P., VOLPE, V., PIAZZA, G., MONGIOVÌ, R., MEZZATESTA, G., ANDRONICO, G., CERASOLA, G.

    Published in Journal of internal medicine (01-06-2005)
    “… Objectives.  The aim of our study was to analyse, in a wide group of essential hypertensive patients without diabetes mellitus, the influence of metabolic…”
    Get full text
    Journal Article
  2. 2

    Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients by Cottone, Santina, Mulè, Giuseppe, Guarneri, Marco, Palermo, Alessandro, Lorito, Maria C., Riccobene, Raffaella, Arsena, Rosalia, Vaccaro, Francesco, Vadalà, Anna, Nardi, Emilio, Cusimano, Paola, Cerasola, Giovanni

    Published in Nephrology, dialysis, transplantation (01-02-2009)
    “…Background. Hypertension and additional non-traditional risk factors can damage the kidney directly and by promoting atherogenesis. Evidence indicates that…”
    Get full text
    Journal Article
  3. 3

    Impact of type 2 diabetes on left ventricular geometry and diastolic function in hypertensive patients with chronic kidney disease by Nardi, E, Palermo, A, Mulè, G, Cusimano, P, Cottone, S, Cerasola, G

    Published in Journal of human hypertension (01-03-2011)
    “…Left ventricular hypertrophy (LVH) and diastolic dysfunction are very common in patients with chronic kidney disease (CKD). Aim of this study was to evaluate…”
    Get full text
    Journal Article
  4. 4

    Young woman with branchio-oto-renal syndrome and a novel mutation in the EYA-1 gene by Nardi, E, Palermo, A, Cusimano, P, Mulè, G, Cerasola, G

    Published in Clinical nephrology (01-10-2011)
    “…Branchio-oto-renal (BOR) syndrome is an autosomal dominant disease clinically characterized by the coexistence of some or all of the following major disorders:…”
    Get more information
    Journal Article
  5. 5

    Inverse Relationship Between Ambulatory Arterial Stiffness Index and Glomerular Filtration Rate in Arterial Hypertension by Mulè, Giuseppe, Cottone, Santina, Cusimano, Paola, Incalcaterra, Francesca, Giandalia, Maria, Costanzo, Miriam, Nardi, Emilio, Palermo, Alessandro, Geraci, Calogero, Costa, Renato, Cerasola, Giovanni

    Published in American journal of hypertension (01-01-2008)
    “…Background Arterial stiffness and mild-to-moderate renal dysfunction are predictors of cardiovascular (CV) morbidity and mortality. Recently, the ambulatory…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Clinical correlates of renal dysfunction in hypertensive patients without cardiovascular complications: the REDHY study by Cerasola, G, Mulè, G, Nardi, E, Cusimano, P, Palermo, A, Arsena, R, Guarneri, M, Geraci, C, Cottone, S

    Published in Journal of human hypertension (01-01-2010)
    “…Our study was aimed to assess the clinical correlates of different degrees of renal dysfunction in a wide group of non-diabetic hypertensive patients, free…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function by MULE, G, NARDI, E, COTTONE, S, CUSIMANO, P, INCALCATERRA, F, PALERMO, A, GIANDALIA, M, GERACI, C, BUSCEMI, S, CERASOLA, G

    Published in Journal of human hypertension (01-11-2007)
    “…Some reports have suggested that white-coat hypertension (WCH) is associated with some features of the metabolic syndrome (MetS). These metabolic disturbances,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Relationships between metabolic syndrome and left ventricular mass in hypertensive patients: does sex matter? by Mulè, G, Cusimano, P, Nardi, E, Cottone, S, Geraci, C, Palermo, A, Costanzo, M, Foraci, A C, Cerasola, G

    Published in Journal of human hypertension (01-11-2008)
    “…Several studies documented an association between metabolic syndrome (MetS) and left ventricular (LV) hypertrophy. However, only in a few of these studies the…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels by BERTELLI, G, PRONZATO, P, AMOROSO, D, CUSIMANO, M. P, CONTE, P. F, MONTAGNA, G, BERTOLINI, S, ROSSO, R

    Published in Breast cancer research and treatment (01-12-1988)
    “…The possible estrogenic effects of tamoxifen on plasma lipids and antithrombin III levels were investigated in 91 breast cancer patients. Mean values of total,…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20